A Clinical Trial to Evaluate the Effects of Rejuvaskin Eczema Body Wash and Skin Recovery Cream in Adults With Eczema-Prone Skin
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 35
- 试验地点
- 1
- 主要终点
- Change from Baseline in Self-Reported Skin Dryness
研究概览
简要总结
This is a single-arm, open-label, decentralized (fully remote) clinical trial evaluating the tolerability and self-perceived skin effects of Rejuvaskin Eczema Body Wash and Skin Recovery Cream in 35 adults aged 18-65 with self-reported eczema-prone skin. Participants will use the body wash once daily in place of their usual cleanser, followed by the Skin Recovery Cream, for 4 consecutive weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult women or men aged 18-65 years.
- •Self-reported symptoms of eczema or eczema-prone skin (e.g., dryness, roughness, itching, irritation on the body).
- •Visible signs of eczema such as dryness, roughness, or irritation on at least one part of the body at the time of enrollment.
- •Willing to use Rejuvaskin Eczema Body Wash once daily as their primary body cleanser for 4 consecutive weeks.
- •Willing to use Rejuvaskin Skin Recovery Cream once daily after using the - Rejuvaskin body cleanser for 4 consecutive weeks.
- •Willing to maintain their current diet, skincare routine (aside from substitution of body wash and skin cream), and lifestyle habits for the study duration.
- •Willing and able to take standardized photographs of an affected body area at Baseline and Week 4 using a personal smartphone.
- •Able to read, understand, and complete questionnaires in English.
- •Resides in the United States with a valid shipping address.
- •Willing to provide informed consent and comply with all study procedures
排除标准
- •Known allergy or sensitivity to any ingredient in the study product.
- •Currently pregnant, breastfeeding, or planning to become pregnant during the study period.
- •Active, severe skin condition on the body requiring prescription topical or systemic treatment (e.g., active severe atopic dermatitis flare under medical care, active infection at intended application sites).
- •Currently using prescription topical corticosteroids, calcineurin inhibitors, or other prescription topical eczema treatments on the body, or initiation of such treatment planned during the study.
- •Currently participating in another clinical or skincare research study, or planning to enroll during this study's duration. (
研究组 & 干预措施
Rejuvaskin Eczema Body Wash Arm
干预措施: Rejuvaskin Eczema Body Wash (Dietary Supplement)
结局指标
主要结局
Change from Baseline in Self-Reported Skin Dryness
时间窗: Baseline to Week 4
Mean change in self-reported dryness measured via a structured self-report questionnaire administered through the Citruslabs platform
Change from Baseline in Self-Reported Skin Roughness
时间窗: Baseline to Week 4
Mean change in self-reported roughness measured via a structured self-report questionnaire administered through the Citruslabs platform
Change from Baseline in Self-Reported Skin Itch
时间窗: Baseline to Week 4
Mean change in self-reported itch measured via a structured self-report questionnaire administered through the Citruslabs platform
Change from Baseline in Self-Reported Skin Irritation
时间窗: Baseline to Week 4
Mean change in self-reported irritation measured via a structured self-report questionnaire administered through the Citruslabs platform
Change from Baseline in Self-Reported Skin Discomfort
时间窗: Baseline to Week 4
Mean change in self-reported discomfort measured via a structured self-report questionnaire administered through the Citruslabs platform
次要结局
- Change from Baseline in Self-Reported Skin Hydration(Baseline to Week 4)
- Change from Baseline in Self-Reported Skin Comfort(Baseline to Week 4)
- Expert Dermatologist-Graded Change in Erythema(Baseline and Week 4)
- Expert Dermatologist-Graded Change in Scaling(Baseline and Week 4)